Literature DB >> 33390153

Determinants of uptake of malaria preventive interventions among pregnant women in eastern Uganda.

Solomon Tsebeni Wafula1,2, Hilbert Mendoza3,4, Aisha Nalugya3, David Musoke3, Peter Waiswa5.   

Abstract

BACKGROUND: Consistent use of insecticide-treated nets (ITNs) and intermittent preventive treatment in pregnancy (IPTp) have been recommended as cost-effective interventions for malaria prevention during pregnancy in endemic areas. However, the coverage and utilization of these interventions during pregnancy in sub-Saharan Africa is still suboptimal. This study aimed to determine the uptake of IPTp and ITNs and associated factors among women during their recent pregnancy in Eastern Uganda.
METHODS: This was a cross-sectional study conducted among 2062 women who had delivered within the last 12 months prior to the start of the study in three districts of Eastern Uganda. The primary outcomes were consistent ITN use and optimal uptake (at least 3 doses) of IPTp. A modified Poisson regression was used to examine the association between consistent ITN use and the uptake of optimal doses of IPTp with independent variables. Data were analysed using Stata 14 software.
RESULTS: The level of uptake of IPTp3 (at least three doses) was 14.7%, while IPTp2 (at least two doses) was 60.0%. The majority (86.4%) of mothers reported regularly sleeping under mosquito nets for the full duration of pregnancy. Uptake of IPTp3 was associated with engaging in farming (adjusted PR = 1.71, 95% CI [1.28-2.28]) or business (adjusted PR = 1.60, 95% CI [1.05-2.44]), and attending at least 4 antenatal care (ANC) visits (adjusted PR = 1.72, 95% CI [1.34-2.22]). On the other hand, consistent ITN use was associated with belonging to the fourth wealth quintile (adjusted PR = 1.08, 95% CI [1.02-1.14]) or fifth wealth quintile (adjusted PR = 1.08, 95% CI [1.02-1.15]), and attending at least 4 ANC visits (adjusted PR = 1.07, 95% CI [1.03-1.11]).
CONCLUSION: Uptake of IPTp3 and consistent ITN use during pregnancy were lower and higher than the current Ugandan national targets, respectively. Study findings highlight the need for more efforts to enhance utilization of ANC services, which is likely to increase the uptake of these two key malaria preventive measures during pregnancy.

Entities:  

Keywords:  Eastern Uganda; IPTp3 uptake; ITN use; Malaria preventive interventions; Pregnant women

Mesh:

Substances:

Year:  2021        PMID: 33390153      PMCID: PMC7780677          DOI: 10.1186/s12936-020-03558-1

Source DB:  PubMed          Journal:  Malar J        ISSN: 1475-2875            Impact factor:   2.979


  18 in total

1.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

Review 2.  Epidemiology and burden of malaria in pregnancy.

Authors:  Meghna Desai; Feiko O ter Kuile; François Nosten; Rose McGready; Kwame Asamoa; Bernard Brabin; Robert D Newman
Journal:  Lancet Infect Dis       Date:  2007-02       Impact factor: 25.071

3.  Intermittent preventive treatment of malaria in pregnancy: a new delivery system and its effect on maternal health and pregnancy outcomes in Uganda.

Authors:  A K Mbonye; I C Bygbjerg; P Magnussen
Journal:  Bull World Health Organ       Date:  2008-02       Impact factor: 9.408

4.  Utilisation of insecticide treated nets among pregnant women in Gulu: a post conflict district in northern Uganda.

Authors:  J H Obol; S Ononge; C G Orach
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

5.  Factors associated with uptake of optimal doses of intermittent preventive treatment for malaria among pregnant women in Uganda: analysis of data from the Uganda Demographic and Health Survey, 2016.

Authors:  Denis Okethwangu; Jimmy Opigo; Stella Atugonza; Catherine T Kizza; Monica Nabatanzi; Claire Biribawa; Daniel Kyabayinze; Alex R Ario
Journal:  Malar J       Date:  2019-07-26       Impact factor: 2.979

6.  Wealth and antenatal care use: implications for maternal health care utilisation in Ghana.

Authors:  Eric Arthur
Journal:  Health Econ Rev       Date:  2012-08-06

7.  Determinants of use of insecticide treated nets for the prevention of malaria in pregnancy: Jinja, Uganda.

Authors:  Laura R Sangaré; Noel S Weiss; Paula E Brentlinger; Barbra A Richardson; Sarah G Staedke; Mpungu S Kiwuwa; Andy Stergachis
Journal:  PLoS One       Date:  2012-06-22       Impact factor: 3.240

8.  Determinants of maternal health service utilization in Ethiopia: analysis of the 2011 Ethiopian Demographic and Health Survey.

Authors:  Shegaw Mulu Tarekegn; Leslie Sue Lieberman; Vincentas Giedraitis
Journal:  BMC Pregnancy Childbirth       Date:  2014-05-07       Impact factor: 3.007

9.  Factors Influencing Anti-Malarial Prophylaxis and Iron Supplementation Non-Compliance among Pregnant Women in Simiyu Region, Tanzania.

Authors:  Benatus Sambili; Ronald Kimambo; Yun Peng; Elison Ishunga; Edna Matasha; Godfrey Matumu; Rita Noronha; David P Ngilangwa
Journal:  Int J Environ Res Public Health       Date:  2016-06-23       Impact factor: 3.390

10.  Factors associated with use of malaria control interventions by pregnant women in Buwunga subcounty, Bugiri District.

Authors:  Elizabeth Muhumuza; Noel Namuhani; Bonny Enock Balugaba; Jessica Namata; Elizabeth Ekirapa Kiracho
Journal:  Malar J       Date:  2016-07-04       Impact factor: 2.979

View more
  2 in total

1.  Treatment-seeking and uptake of malaria prevention strategies among pregnant women and caregivers of children under-five years during COVID-19 pandemic in rural communities in South West Uganda: a qualitative study.

Authors:  Ivan Mugisha Taremwa; Scholastic Ashaba; Rose Kyarisiima; Carlrona Ayebazibwe; Ruth Ninsiima; Cristina Mattison
Journal:  BMC Public Health       Date:  2022-02-21       Impact factor: 3.295

2.  Factors associated with non-use of insecticide-treated bed nets among pregnant women in Zambia.

Authors:  Luwi Mercy Mwangu; Relebogile Mapuroma; Latifat Ibisomi
Journal:  Malar J       Date:  2022-10-11       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.